Acute onset of halos and glare: Bilateral corneal epithelial edema with cystic eruptions—atypical presentation of amiodarone keratopathy

Murray, 2002, 3487 Podrid, 1995, Amiodarone, Ann Intern Med, 122, 689, 10.7326/0003-4819-122-9-199505010-00008 Hendeles, 1990, Treatment failure after substitution of generic pancrelipase capsules, JAMA, 263, 2459, 10.1001/jama.1990.03440180065033 Hilleman, 2000, Adverse effects and monitoring of long-term oral amiodarone administration in amiodarone, American Council on Pharmaceutical Education Banahan, 1997, A physician survey on generic drugs and substitution of critical dose mediations, Arch Intern Med, 157, 2080, 10.1001/archinte.1997.00440390066010 Meyer, 1998, Generic drug product equivalence, Am J Manag Care, 4, 1183 Hilleman, 1998, Optimal management of amiodarone therapy, Pharmacotherapy, 18, 138S Nightingale, 1987, Generic substitution, JAMA, 258, 1200, 10.1001/jama.258.9.1200 Vasquez, 1999, Transplant pharmacists’ opinions on generic product selection of critical-dose drugs, Am J Health Syst Pharm, 1, 615, 10.1093/ajhp/56.7.615 Sabatini, 1999, Drug substitution in transplantation, Am J Kidney Dis, 33, 389, 10.1016/S0272-6386(99)70318-5 Benet, 1995, Bioequivalence and narrow therapeutic index drugs, Pharmacotherapy, 15, 433 Williams, 1997, FDA position on product selection for ‘narrow therapeutics index’ drugs, Am J Health Syst Pharm, 54, 1630, 10.1093/ajhp/54.14.1630 Reasor, 2001, Drug-induced phospholipidosis, Exp Biol Med, 226, 825, 10.1177/153537020122600903 Scuntaro, 1996, Inhibition by vitamin E of drug accumulation and of phospholipidosis induced by desipramine and other cationic amphiphilic drugs in human cultured cells, Br J Pharmacol, 119, 829, 10.1111/j.1476-5381.1996.tb15747.x Arffa, 1997, Approach to Diseases of the Cornea, 191 Lüllmann-Rauch, 1979, Drug-induced lysosomal storage disorders, Vol. 6, 49 Castells, 2002, Visual changes secondary to initiation of amiodarone, Optometry, 73, 113 Ghosh, 1984, Amiodarone-induced ultrastructural changes in human eyes, Can J Ophthalmol, 19, 178 Swann, 1999, Ocular complications from amiodarone, Optometry Today, 16, 34 Mansour, 1988, Optic nerve ultrastructure following amiodarone therapy, J Clin Neuroophthalmol, 8, 231 Lawrenson, 2002, Toxicology of the Eye—Part 1, Optician, 224, 20 Orlando, 1984, Clinical experience and grading of amiodarone keratopathy, Ophthalmology, 91, 1184, 10.1016/S0161-6420(84)34165-3 Mantyjarvi, 1998, Ocular side effects of amiodarone, Surv Ophthalmol, 42, 360, 10.1016/S0039-6257(97)00118-5 Ingram, 1983, Ocular effects in long-term amiodarone therapy, Am Heart J, 106, 902, 10.1016/0002-8703(83)90014-5 Kolatkar, 1997, Antiarrhythmic Agents, 9 Nielen, 1983, Amiodarone induced cornea verticillata, Acta Ophthalmol (Copenh), 61, 474, 10.1111/j.1755-3768.1983.tb01447.x Mastropasqua, 2002, Corneal Microdeposits, 47 Yagmur, 2003, Confocal microscopic features of amiodarone keratopathy, J Toxicol, 22, 243 Patalano, 2002, Amiodarone corneal topography, Dig J Ophthalmol